182 related articles for article (PubMed ID: 25649484)
21. RocA Regulates Phosphatase Activity of Virulence Sensor CovS of Group A
Chiang-Ni C; Chiou HJ; Tseng HC; Hsu CY; Chiu CH
mSphere; 2020 May; 5(3):. PubMed ID: 32434842
[TBL] [Abstract][Full Text] [Related]
22. RivR is a negative regulator of virulence factor expression in group A Streptococcus.
Treviño J; Liu Z; Cao TN; Ramirez-Peña E; Sumby P
Infect Immun; 2013 Jan; 81(1):364-72. PubMed ID: 23147037
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of the cysteine protease SpeB affects hyaluronic acid capsule expression in group A streptococci.
Woischnik M; Buttaro BA; Podbielski A
Microb Pathog; 2000 Apr; 28(4):221-6. PubMed ID: 10764613
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection.
Engleberg NC; Heath A; Miller A; Rivera C; DiRita VJ
J Infect Dis; 2001 Apr; 183(7):1043-54. PubMed ID: 11237829
[TBL] [Abstract][Full Text] [Related]
25. Transcription of the Streptococcus pyogenes hyaluronic acid capsule biosynthesis operon is regulated by previously unknown upstream elements.
Falaleeva M; Zurek OW; Watkins RL; Reed RW; Ali H; Sumby P; Voyich JM; Korotkova N
Infect Immun; 2014 Dec; 82(12):5293-307. PubMed ID: 25287924
[TBL] [Abstract][Full Text] [Related]
26. The Bacterial Markers of Identification of Invasive CovR/CovS-Inactivated Group A
Shi YA; Chen TC; Chen YW; Liu YS; Chen YM; Lai CH; Chiu CH; Chiang-Ni C
Microbiol Spectr; 2022 Oct; 10(5):e0203322. PubMed ID: 36200903
[TBL] [Abstract][Full Text] [Related]
27. Genetic characterization and virulence role of the RALP3/LSA locus upstream of the streptolysin s operon in invasive M1T1 Group A Streptococcus.
Kwinn LA; Khosravi A; Aziz RK; Timmer AM; Doran KS; Kotb M; Nizet V
J Bacteriol; 2007 Feb; 189(4):1322-9. PubMed ID: 17114267
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.
Wessels MR; Moses AE; Goldberg JB; DiCesare TJ
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8317-21. PubMed ID: 1656437
[TBL] [Abstract][Full Text] [Related]
29. covR Mediated Antibiofilm Activity of 3-Furancarboxaldehyde Increases the Virulence of Group A Streptococcus.
Ashwinkumar Subramenium G; Viszwapriya D; Iyer PM; Balamurugan K; Karutha Pandian S
PLoS One; 2015; 10(5):e0127210. PubMed ID: 25978065
[TBL] [Abstract][Full Text] [Related]
30. Cellular interactions of covR/S mutant group A Streptococci.
Langshaw EL; Pandey M; Good MF
Microbes Infect; 2018; 20(9-10):531-535. PubMed ID: 29287985
[TBL] [Abstract][Full Text] [Related]
31. Homologous role of CovRS two-component regulatory system in NAD
Hasegawa T; Matsumoto M; Hata N; Yano H; Isaka M; Tatsuno I
APMIS; 2019 Feb; 127(2):87-92. PubMed ID: 30698306
[TBL] [Abstract][Full Text] [Related]
32. Single Amino Acid Replacements in RocA Disrupt Protein-Protein Interactions To Alter the Molecular Pathogenesis of Group A
Bernard PE; Duarte A; Bogdanov M; Musser JM; Olsen RJ
Infect Immun; 2020 Oct; 88(11):. PubMed ID: 32817331
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface.
Dinkla K; Sastalla I; Godehardt AW; Janze N; Chhatwal GS; Rohde M; Medina E
Microbes Infect; 2007 Jul; 9(8):922-31. PubMed ID: 17544803
[TBL] [Abstract][Full Text] [Related]
34. High-frequency intracellular infection and erythrogenic toxin A expression undergo phase variation in M1 group A streptococci.
Cleary PP; McLandsborough L; Ikeda L; Cue D; Krawczak J; Lam H
Mol Microbiol; 1998 Apr; 28(1):157-67. PubMed ID: 9593304
[TBL] [Abstract][Full Text] [Related]
35. Induction of group A Streptococcus virulence by a human antimicrobial peptide.
Gryllos I; Tran-Winkler HJ; Cheng MF; Chung H; Bolcome R; Lu W; Lehrer RI; Wessels MR
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16755-60. PubMed ID: 18936485
[TBL] [Abstract][Full Text] [Related]
36. Dual-site phosphorylation of the control of virulence regulator impacts group a streptococcal global gene expression and pathogenesis.
Horstmann N; Saldaña M; Sahasrabhojane P; Yao H; Su X; Thompson E; Koller A; Shelburne SA
PLoS Pathog; 2014 May; 10(5):e1004088. PubMed ID: 24788524
[TBL] [Abstract][Full Text] [Related]
37. Partial loss of CovS function in Streptococcus pyogenes causes severe invasive disease.
Tatsuno I; Okada R; Zhang Y; Isaka M; Hasegawa T
BMC Res Notes; 2013 Mar; 6():126. PubMed ID: 23537349
[TBL] [Abstract][Full Text] [Related]
38. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus.
Levin JC; Wessels MR
Mol Microbiol; 1998 Oct; 30(1):209-19. PubMed ID: 9786197
[TBL] [Abstract][Full Text] [Related]
39. Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling.
Graham MR; Smoot LM; Migliaccio CA; Virtaneva K; Sturdevant DE; Porcella SF; Federle MJ; Adams GJ; Scott JR; Musser JM
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13855-60. PubMed ID: 12370433
[TBL] [Abstract][Full Text] [Related]
40. The PerR regulon in peroxide resistance and virulence of Streptococcus pyogenes.
Brenot A; King KY; Caparon MG
Mol Microbiol; 2005 Jan; 55(1):221-34. PubMed ID: 15612930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
